Rheiazymes Pioneer Molecular Bio Recycling Technology

It is with a heavy heart, but with strong conviction, that we share this news with you today. We regret to inform you that Rheiazymes and the YARN-TO-YARN® project have had to enter the liquidation process despite our best efforts and numerous alternatives explored.

Despite the tireless efforts of our team and the tremendous support of our investors and our funding partner, the Migros Pioneer Fund, we find ourselves at a crossroads where we lack the necessary funding to move forward with our vision. The significantly longer development process for scaling the technology made it impossible to obtain the necessary financing for the company. We have not taken this decision lightly, but with the utmost consideration for our stakeholders and the future of enzymatic recycling. Accordingly, we will also share our knowledge and findings with you and the public in the coming weeks in order to maximize our impact. Here, too, we are supported by the Migros Pioneer Fund.

Even though this chapter is now coming to an end, we are very proud of what we have achieved together. Our journey has been characterized by innovation, collaboration and resilience. We have pushed boundaries, challenged industry norms and dared to dream big. To our team, investors, partners and supporters: we thank you! Your belief in our mission has been the driving force behind every step we have taken. While this may be the end of one journey, it is at the same time the beginning of countless new opportunities. Let's continue to carry the torch of innovation, knowing that the impact of Rheiazymes and YARN-TO-YARN® will last well beyond these difficult times.

As we manage this transition, we remain committed to transparency, integrity and the well-being of all stakeholders. We will continue to communicate openly and offer support wherever possible.

Thank you for being part of our journey.